Drug
Abt 199
Abt 199: highest development phase Phase 1, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| ABT-199 NCT01969669 | Phase 1 | Non-Hodgkin's Lymphoma |
Latest
No recent events.
Follow Abt 199 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.